Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals has submitted to NSE and BSE a certificate from its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited, confirming compliance with SEBI's Regulation 74(5) for the quarter ended 30th June 2025. The certificate confirms that all securities received from depository participants for demat during the quarter were properly processed, with demat requests accepted or rejected as applicable. The original share certificates received were mutilated and cancelled after verification, and the names of the depositories have been substituted as the registered owners in the company's register of members within prescribed timelines. The filing was signed by the Company Secretary, Dharamvir Malik.
This is a routine quarterly regulatory compliance filing required of all listed companies and has no material impact on shareholders or the stock price. It simply confirms that the company's demat-related administrative processes are functioning normally.